Highnoon Laboratories Limited reported a net profit of Rs 955.68 million for the first quarter of 2026

Filed as: Financial Results for the Quarter Ended 31.03.2026

HINOONHighnoon Laboratories LimitedHINOON · PharmaceuticalsFinancial resultFiled Pakistan time

Summary

Highnoon Laboratories Limited reported a net profit of Rs 955.68 million for the first quarter of 2026, with revenue reaching Rs 6.81 billion. The company showed a moderate increase in both revenue and profit compared to the same period last year.

Read the original filing

Figures in the filing

ItemThis periodPeriod beforeChange
RevenuePKR 6.81 billionPKR 6.55 billion+4.1%
Net ProfitPKR 955.68 millionPKR 915.64 million+4.4%
Earnings Per Share (EPS)PKR 18.04PKR 17.28+4.4%
Gross ProfitPKR 3.85 billionPKR 3.39 billion+13.6%
Cash and Bank BalancesPKR 751.97 millionPKR 468.80 million+60.4%

Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).

What the filing says

  • Revenue increased to Rs 6.81 billion from Rs 6.55 billion, showing a growth of 4.06% compared to the prior period.
  • Net profit rose to Rs 955.68 million from Rs 915.64 million, marking a growth of 4.38% year-over-year.
  • Earnings per share improved to Rs 18.04 from Rs 17.28, indicating a positive trend in profitability.

Highnoon Laboratories Limited (HINOON) on Nafa

Last price Rs 960.87 · Pharmaceuticals · You can own HINOON shares from your phone.

More HINOON announcements

All HINOON announcements

Source: Highnoon Laboratories Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.